Company profile: Bacterial Barcodes
1.1 - Company Overview
Company description
- Provider of equipment, reagents, and software for microbial genotyping of bacteria and fungi, packaged as the DiversiLab System, serving the clinical diagnostic market for bacterial identification.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bacterial Barcodes
Spectrum Antimicrobials
HQ: United States
Website
- Description: Provider of pharmaceutical drug development specializing in antibiotics and therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spectrum Antimicrobials company profile →
Discuva
HQ: United Kingdom
Website
- Description: Provider of next-generation antibiotic discovery, Cambridge (UK)-based, established to address major gaps in the treatment of infective disease using proprietary methods, and developer of Ivonescimab (SMT112), a bispecific PD-1/VEGF antibody for oncology in Phase III trials for non-small cell lung cancer and other solid tumors, with over 1,600 patients treated.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Discuva company profile →
MYR Pharma
HQ: Germany
Website
- Description: Provider of biotechnological treatments focused on hepatitis B and hepatitis D.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MYR Pharma company profile →
Qpex Biopharma
HQ: United States
Website
- Description: Provider of antibiotic agents addressing critical needs in infectious disease treatment and antimicrobial resistance for inpatient and outpatient care. Portfolio includes QPX7728, an ultra-broad-spectrum beta-lactamase inhibitor; OMNIvance (Xeruborbactam + Meropenem) for gram-negative infections; ORAvance, an oral Xeruborbactam prodrug enhancing oral beta-lactams; and QPX9003, a lipopeptide for MDR gram-negative pathogens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qpex Biopharma company profile →
Spring Bank Pharmaceuticals
HQ: United States
Website
- Description: Provider of small molecule nucleic acid hybrid-based therapeutics and immuno-oncology candidates, including FS118, a LAG-3/PD-L1 mAb2 bispecific antibody in Phase 2 for head and neck cancer, NSCLC and DLBCL; FS120, an OX40/CD137 dual agonist mAb2 in Phase 1; FS222, a CD137/PD-L1 mAb2 in Phase 1 for PD-L1-low tumors; and SB 11285, an IV second-generation STING agonist in Phase 1, alone and with atezolizumab.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spring Bank Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bacterial Barcodes
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bacterial Barcodes
2.2 - Growth funds investing in similar companies to Bacterial Barcodes
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bacterial Barcodes
4.2 - Public trading comparable groups for Bacterial Barcodes
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →